Engflag

Hydrozone

Quick links to important sections

Hydrozone

Hydrozone_ES

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hydrozone

Property Description
Active ingredient Hydrocortisone, Hydrocortisone sodium succinate
Form Sterile Powder for Solution for Injection (Parenteral preparation)
Pharmacological class Corticosteroid (Synthetic Glucocorticoid)
General purpose Modulating systemic inflammation and immune activity
Origin Synthetic compound

What Type of Medicine is Hydrozone?

Hydrozone is primarily defined as a potent synthetic glucocorticoid, a type of adrenocortical steroid structurally and functionally similar to the body's natural hormone, cortisol. Glucocorticoids are a class of steroid hormones that quickly and comprehensively affect various systems throughout the body. As such, the medicine acts broadly and rapidly to influence the body’s internal environment.

As a member of the corticosteroid class, Hydrozone is a prescription-only (Rx-only) product designated for systemic use. Its role as a synthetic compound is clinically recognized for providing a controlled, high-impact hormonal effect, which is critical for acute intervention in scenarios demanding immediate relief, particularly in cases of adrenocortical deficiency states.

Hydrozone Composition: Hydrocortisone and the Sodium Succinate Form

The core active compound is Hydrocortisone, but it is specifically formulated as Hydrocortisone sodium succinate to ensure maximum solubility and rapid action via injection. This highly water-soluble sodium succinate ester of hydrocortisone is supplied as a sterile powder for solution for injection, making it a parenteral preparation. This specific design allows the medication to be administered via the intravenous or intramuscular route, which is essential for ensuring an immediate onset of action and rapidly achieving high concentrations in the bloodstream.

General Purpose: Controlling Systemic Inflammation and Immune Activity

The general purpose of Hydrozone is to quickly and profoundly modulate the body's inflammatory and immune responses. The medication achieves its effect by suppressing multiple inflammatory pathways and modifying the body's immune response to diverse stimuli. The fundamental benefit is the rapid and immediate reduction of potentially harmful systemic inflammation and immune overactivity, helping to stabilize the patient's internal balance when these critical systems are severely dysregulated.

Regulatory References

  1. Physiology, Glucocorticoids - NIH StatPearls
  2. Glucocorticoid Receptor Signaling in Health and Disease - NIH/PMC

What side effects are possible with Hydrozone?

Possible side effects and safety information

The officially documented safety profile of Hydrozone (Hydrocortisone sodium succinate) is defined by its action as a potent systemic glucocorticoid, resulting in adverse reactions across multiple physiological systems. The occurrence and severity of many effects are explicitly related to the dose used and the duration of therapy, as documented by regulatory authorities.

System-Organ Safety Classifications

Adverse reactions are formally classified into categories such as Endocrine Disorders (e.g., HPA axis suppression), Metabolism and Nutrition Disorders (e.g., fluid retention, hyperglycemia), Musculoskeletal and Connective Tissue Disorders (e.g., muscle weakness, osteoporosis), and Psychiatric Disturbances (e.g., insomnia, mood swings).

Serious Adverse Reactions and Safety Patterns

Serious adverse reactions reported in regulatory documents include Anaphylactic Reactions, Peptic Ulceration with potential for perforation and haemorrhage, and the possibility of Increased Intracranial Pressure (pseudotumour cerebri). Long-term exposure is associated with increased risk for conditions like Cushingoid state and cataracts. Abrupt cessation of prolonged treatment carries a documented risk of Adrenocortical Insufficiency and Steroid Withdrawal Syndrome.

Population-Specific Safety and Restrictions

Special safety considerations are documented for specific groups: Children carry a risk of growth suppression, and older adults have an increased risk of common adverse reactions, including osteoporosis and hypertension. The medicine is formally restricted from use in patients with systemic fungal infections and is not indicated for administration with live or live attenuated vaccines due to its immunosuppressive nature.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory profile for Hydrozone (Hydrocortisone sodium succinate) focuses on the known effects of supra-physiological (very high) doses, as official labeling notes a lack of specific experience with acute overdosage of the injectable form. The main manifestations of high-dose exposure involve severe fluid and electrolyte imbalance.

Documented Manifestations and Actions

Overdose may present with signs of mineralocorticoid effect, including elevation of blood pressure, salt and water retention, and increased excretion of potassium. Prolonged high-dose use can lead to hypernatremia and clinical features resembling Cushing’s syndrome. Uncommonly, peptic ulceration is associated with high-dose, short-term use.

Action/Procedure Requirement
Immediate Medical Help Must be sought for any suspected overdose.
Poison Control Contact a regional Poison Control center for guidance.
Antidote Availability No specific antidote is known.

Management focuses strictly on symptomatic and supportive treatment. This includes mandatory monitoring of electrolytes in serum and urine—specifically sodium and potassium balance—and maintaining adequate fluid intake to manage the documented high-dose effects.

Therapeutic Uses of Hydrozone

What Hydrozone Treats: Main Uses and Benefits

Therapeutic Indications and Benefits

Hydrozone is commonly used to help with symptom clusters that may become intense or disruptive and create noticeable functional strain. The medication is considered relevant across conditions presenting with acute episodes and those characterized by periods of heightened symptoms.

Its therapeutic applications may be part of symptomatic management for distressing symptoms. Specifically, it is relevant for easing symptoms related to allergic skin reactions, may assist with managing anxiety and tension, and contributes to easing the overall symptom load during periods of heightened physiological activity.

This medication may provide support that helps ease the overall symptom burden during periods of heightened symptoms. It supports patients during episodes of heightened discomfort and may help patients cope more steadily with symptom fluctuations when conditions involve episodic or fluctuating manifestations.

Quick Fact: Support for Acute Discomfort

Hydrozone is commonly used in clinical settings that involve acute or disruptive symptom patterns, where short-term symptomatic assistance is needed to support general well-being.

Regulatory References

  1. NIH MedlinePlus overview of Hydroxyzine

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Hydrozone

Official regulatory documentation defines eligibility for Hydrozone (Hydrocortisone sodium succinate) through absolute contraindications and strict condition-based limitations.

Absolute Exclusions

Use is strictly contraindicated in patients with systemic fungal infections or known hypersensitivity to the drug or its components. Administration via the intrathecal or epidural routes is prohibited. Furthermore, Intramuscular administration is contraindicated for patients with Idiopathic Thrombocytopenic Purpura (ITP).

Age and Condition Limitations

Hydrozone is generally approved for adult, geriatric, and pediatric patients. However, prolonged use in children is noted to interfere with growth and development. The medicine requires special caution in patients with conditions like liver disease (cirrhosis), hypertension, congestive heart failure, and diabetes mellitus due to potential altered effects or increased risks.

Pregnancy Status

The parenteral form is classified as FDA Pregnancy Category C. Use during pregnancy is permitted only when the potential benefit is judged to outweigh the potential risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Hydrozone (Hydrocortisone sodium succinate) is formally documented based on its systemic glucocorticoid activity and metabolic pathway.

Pharmacokinetic and Metabolic Interactions

Co-administration with other medicines can significantly modify Hydrozone's plasma exposure, primarily through interaction with the CYP3A4 enzyme system.

  • CYP3A4 Inducers (e.g., Rifampicin, Phenytoin): These substances may reduce the serum concentration of Hydrozone, potentially decreasing its systemic exposure.
  • CYP3A4 Inhibitors (e.g., Ketoconazole, Erythromycin, Grapefruit Juice): These substances may increase the plasma concentrations of Hydrozone, due to decreased metabolism and clearance.

Pharmacodynamic and Administration Restrictions

Official labeling identifies several drug classes where Hydrozone's co-administration results in additive or opposing effects:

  • Diuretics: Combination with thiazide or loop diuretics enhances the risk of hypokalemia.
  • Anticoagulants: The effect of coumarin-type anticoagulants may be altered, requiring close monitoring.
  • Hypoglycemic Agents: Hydrozone may antagonize the desired effects of these agents.
  • Vaccines: Live or live-attenuated vaccines are formally contraindicated in patients receiving immunosuppressive doses of Hydrozone. Inactivated vaccines may result in a diminished immune response.

Official documents also note that due to decreased metabolism, an increased effect of Hydrozone is observed in patients with hepatic impairment.

Mechanism of Action

Molecular Targets and Receptor Activation

Hydrozone works by acting as an agonist on the Glucocorticoid Receptor ( GR), an intracellular protein found across most cell types. Activation of the GR complex initiates a comprehensive GR-mediated signaling cascade, including both genomic (gene-level) and rapid non-genomic effects, which allows for the immediate and extensive modulation of key regulatory pathways.

Inhibition of the Inflammatory Cascade

The GR complex enters the nucleus and employs transrepression to directly repress the genes of major pro-inflammatory mediators, such as cytokines ( IL-6, TNF-alpha). Simultaneously, the mechanism blocks the Arachidonic Acid Cascade by upregulating the protein Annexin A1, which inhibits the PLA2 enzyme needed to form signaling molecules like prostaglandins and leukotrienes. This comprehensive suppression rapidly modifies the signaling output from inflammatory pathways.

Speed of Action and Mechanistic Constraints

The drug is specifically formulated as the highly soluble sodium succinate ester, which enables it to achieve the high plasma concentrations necessary for immediate receptor saturation via rapid intravenous administration. This is required for immediate, widespread engagement of the GR mechanism throughout the body. However, the mechanism may be functionally constrained in scenarios involving Glucocorticoid Resistance, where impaired GR signaling reduces the drug's activity.

Dosage and Administration Information

How to Use Hydrozone

Hydrozone (hydrocortisone sodium succinate) is administered as a sterile powder requiring reconstitution before its use as a systemic corticosteroid. The general principles of its use are governed by official, label-based instructions focusing on rapid administration, dose timing, and limited duration, typically in acute, controlled settings.

Official Administration Guidelines

Instruction Description
Route of Administration The approved routes are intravenous (IV) injection, IV infusion, and intramuscular (IM) injection. IV injection is the primary method for initial, emergency administration.
Dosing Schedule The initial adult dose ranges from 100 mg to 500 mg (hydrocortisone equivalent) and is dependent on the severity of the condition being addressed. Subsequent doses may be repeated at intervals of 2, 4, or 6 hours.
Preparation Requirements The powder must be reconstituted by adding a small volume of a suitable diluent, such as Bacteriostatic Water for Injection. For IV infusion, the resulting solution may be further diluted into larger volumes (e.g., 100 mL to 1,000 mL) of compatible fluids.
Administration Rate The intravenous injection should be administered over a specific time, ranging from 30 seconds (for a 100 mg dose) up to 10 minutes (for doses of 500 mg or more).

Duration and Population Rules

Therapy with Hydrozone is typically intended for short-term stabilization, meaning high-dose administration is usually not continued beyond 48 to 72 hours. After this acute period, the protocol requires considering a transition to an oral or longer-acting corticosteroid preparation. For pediatric patients, dosing is often calculated based on body weight or surface area, with the minimum daily dose generally not falling below 25 mg.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hydrozone

Hydrozone (Hydrocortisone Sodium Succinate) was evaluated in a research context that divides its use into two main areas: its foundational role as replacement therapy for a hormonal condition and its use in acute systemic conditions where rapid immune and inflammation modulation may be necessary. The evidence for these uses was studied for how it affects outcomes related to systemic or functional imbalance across these two settings.

Evidence for Use in Acute Adrenal Insufficiency

The use of Hydrozone for an acute adrenal crisis is primarily supported by regulatory consensus and clinical experience, reflecting its established role as replacement therapy. Research examined its use for immediate hormonal replacement.

Studies in this area focus on outcomes monitoring physiological strain or stress and stabilization of vital signs. The evidence base describes patterns related to the restoration of blood cortisol levels and maintenance of blood pressure during the acute crisis phase. Studies contribute to understanding symptom patterns in patients experiencing an acute state of hormonal imbalance.

Evidence for Use in Acute Systemic Conditions (Septic Shock)

Research into Hydrozone's role in acute systemic conditions, such as septic shock (a severe response to infection), is extensive and includes numerous large-scale Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies explored the use of Hydrozone as an adjunctive measure in critically ill patients who were already receiving other support medications.

Trials tracked major outcomes related to systemic or functional imbalance, including patient survival (monitored at 28, 90, and 180 days) and outcomes monitoring physiological strain such as the duration of vasopressor use. The data show patterns related to a shorter duration of vasopressor use, which was observed in some studies during the immediate treatment period.

What Is Still Uncertain About the Research

The available evidence highlights what is known — and what is still uncertain. For acute systemic conditions, findings were mixed on overall patient survival, leading to questions about the optimal timing and subgroup of patients who may be best represented by the studied outcomes.

Evidence quality varies across studies, especially regarding the consistency of results across different continents and critical care settings. Furthermore, comparative evidence is lacking for robust head-to-head trials that would definitively establish the optimal therapeutic approach (e.g., whether to use Hydrozone alone or in combination with other replacement therapies).

Key Studies & References

  1. Hydrocortisone Sodium Succinate Prescribing Information (Parenteral Monograph) - Used to establish regulatory scope and indication for acute use

Frequently Asked Questions (FAQ)

Common questions about Hydrozone (FAQ)

Q: How quickly does Hydrozone usually start working?

A: Hydrozone is designed as a soluble powder administered rapidly into a vein. The medicine is designed for rapid distribution throughout the body to quickly modulate the body's internal environment. Because of this formulation, a rapid onset of effects is typically expected after administration.

Q: How long do the effects of Hydrozone last in the body?

A: Official pharmacokinetic data indicates that the medicine has an elimination half-life typically listed between 1.2 and 2.0 hours. In terms of overall systemic effect, the duration of action for a single dose may be listed as approximately 8 to 12 hours.

Q: Is Hydrozone safe for older adults to use?

A: The use of the medicine is addressed in official documents for the geriatric population. Official documents mention an increased possibility of certain adverse reactions in this age group, including changes in mental status and risks related to bone density.

Q: What are the conditions where Hydrozone is officially not recommended?

A: The official product information lists certain absolute contraindications, which means the medicine's use is excluded under these circumstances, such as in patients with systemic fungal infections. Additionally, special caution and close monitoring are typically advised for individuals with pre-existing conditions like liver disease, high blood pressure, diabetes mellitus, and peptic ulcer disease.

Q: Can Hydrozone be used by people with a history of heart issues?

A: Official documents indicate that special caution is required for patients with heart conditions. This includes individuals with a history of hypertension (high blood pressure) or congestive heart failure. The medicine’s official labeling describes the need for special monitoring in these situations.

Q: Does Hydrozone cause weight changes in most people?

A: Yes, official safety information lists weight gain and increased appetite as potential adverse effects. Weight gain is often associated with fluid retention, which is also a noted side effect in the medicine's safety profile.

Q: Is it common to feel tired while taking Hydrozone?

A: Tiredness, weakness, and general fatigue are all listed among the potential adverse effects associated with the use of the medicine, according to official regulatory documents.

Q: Can I drive or operate machinery after taking Hydrozone?

A: Official labeling advises caution before driving or using tools or machines until the individual knows how the medicine affects them. This is due to potential side effects like dizziness and visual disturbances. Awareness of these potential effects is described in the patient safety information.

Q: Is it normal to have mild stomach upset when starting Hydrozone?

A: Stomach upset, nausea, and vomiting are listed among the potential gastrointestinal side effects described in official labeling. Official documents do not offer guidance on when to seek professional attention for this side effect.

Q: Why do some people need to take Hydrozone for a long time?

A: While Hydrozone is primarily intended for short-term acute care, official documents explain that treatment may need to be continued until the acute condition is stabilized. This prolonged use is often followed by a planned transition to an oral or longer-acting corticosteroid preparation.

Q: Does the body build up a tolerance to Hydrozone over time?

A: Chronic use of systemic corticosteroids is known to cause suppression of the Hypothalamic-Pituitary-Adrenal (HPA) axis, which is the body's functional adaptation to the medication. Because of this, cessation of the medicine is often managed under a specific protocol.

Q: Can Hydrozone affect blood sugar levels?

A: Yes, official documents note that the medicine may increase blood sugar levels, a condition known as hyperglycemia. Official documents state that monitoring for blood sugar changes may be necessary in certain patients.

Q: Is Hydrozone available as an injection or just as a pill?

A: The specific medicine called Hydrozone (Hydrocortisone sodium succinate) is supplied as a sterile powder for reconstitution, which is intended for administration as an injection into a vein or muscle. While the core compound, hydrocortisone, is available in other forms, this preparation is exclusively for parenteral (injectable) use.

Q: Is Hydrozone commonly prescribed for children?

A: The medicine is approved for pediatric use. However, its use in children is frequently related to the management of specific adrenal disorders where the goal is to provide replacement therapy for the body's natural cortisol hormone.

Q: Does Hydrozone require any special monitoring or lab tests?

A: Yes, regulatory documents indicate that monitoring is required, especially when the medicine is used for extended periods. This monitoring helps check for conditions such as HPA axis suppression and changes in blood sugar or blood pressure.

Q: Is it possible to have an allergic reaction to Hydrozone?

A: Yes, official safety information lists allergic reactions, including severe reactions like anaphylaxis, as potential adverse events. A known hypersensitivity to the drug or its components is a formal exclusion for use.

Q: Is it possible for Hydrozone to cause trouble sleeping?

A: Yes, trouble sleeping, also known as insomnia, is listed as a potential side effect. This is classified among the potential psychiatric disturbances associated with the medicine's use.

Q: Do any official documents describe Hydrozone as causing dizziness?

A: Yes, dizziness and lightheadedness are listed among the potential adverse effects in the official prescribing information for the medicine.

Q: Is Hydrozone approved in countries outside of the US?

A: Yes, the medicine is approved and regulated by government health authorities in many regions globally. This includes authorities like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Therapeutic Goods Administration (TGA) in Australia.

Q: Does Hydrozone interact with alcohol consumption?

A: Official warnings note that daily use of alcohol while taking the medicine may increase the risk of gastrointestinal complications, specifically mentioning the potential for stomach bleeding. Official safety information notes this potential risk.

Q: Can Hydrozone cause changes in mood or anxiety?

A: Yes, official documents list changes in mood, mood swings, depression, and anxiety among the potential side effects. These effects are classified as psychiatric disturbances associated with the use of the medicine.

Q: Can Hydrozone be used while breastfeeding?

A: Information suggests the active substance of the medicine appears in human milk. Official guidelines describe the need to consider the potential benefit of the medicine to the mother against the potential risk of exposure to the infant.

Q: How does Hydrozone compare to a generic version of the drug?

A: The active ingredient in Hydrozone is hydrocortisone sodium succinate. This same chemical compound is the active ingredient found in any authorized generic versions of the medicine. Regulatory authorities require that these generic products demonstrate bioequivalence to the brand-name product.

How should Hydrozone be stored and disposed of?

Storage and Stability Constraints

The sterile, unreconstituted powder for injection must be stored at Controlled Room Temperature, which is defined by regulatory bodies as 20 C to 25 C (68 F to 77 F). The product must be kept out of the reach of children.

Condition Maximum Shelf-Life (Post-Reconstitution)
Controlled Room Temperature (Protected from light) 12 hours
Refrigerated Conditions (2 C to 8 C) 24 hours

After reconstitution, the solution must be protected from light when stored at room temperature. The solution must be used only if it is clear and free of particulate matter.

Disposal Instructions

Any unused portion of the prepared solution must be discarded after the designated stability period (12 or 24 hours). Disposal of expired or unused medicine and its container must be carried out in strict accordance with all local and national regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Hydrozone found in:

A-Z Index: